Cargando…

High Serum Asprosin Levels Are Associated with Presence of Metabolic Syndrome

OBJECTIVE: Asprosin, a new adipocytokine, has reportedly been associated with glucose release, dyslipidemia, and insulin resistance (IR). However, the relationship of asprosin with metabolic syndrome (MetS) remains unknown. This study aimed to investigate serum asprosin levels in MetS as well as the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hong, Tao, Li, Jiao-Yang, Wang, Ya-Di, Qi, Xiao-Yan, Liao, Zhe-Zhen, Bhadel, Poonam, Ran, Li, Yang, Jing, Yan, Bin, Liu, Jiang-Hua, Xiao, Xin-Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943292/ https://www.ncbi.nlm.nih.gov/pubmed/33747078 http://dx.doi.org/10.1155/2021/6622129

Ejemplares similares

Prospective Association of Novel Metabolic Indices with Metabolic Syndrome in Middle-Aged and Elderly Chinese
por: Li, Jiao-Yang, et al.
Publicado: (2021)

Asprosin: A Novel Player in Metabolic Diseases
por: Yuan, Mingyang, et al.
Publicado: (2020)

Sensitive asprosin detection in clinical samples reveals serum/saliva correlation and indicates cartilage as source for serum asprosin
por: Morcos, Yousef A. T., et al.
Publicado: (2022)

Association of serum zinc-α2-glycoprotein with non-alcoholic fatty liver disease
por: Qi, Xiao-Yan, et al.
Publicado: (2020)

Increased serum asprosin is correlated with diabetic nephropathy
por: Wang, Rui, et al.
Publicado: (2021)

Serum zinc-α2-glycoprotein levels are elevated and correlated with thyroid hormone in newly diagnosed hyperthyroidism
por: Xiao, Xin-Hua, et al.
Publicado: (2019)

Plasma Asprosin Levels Are Associated with Glucose Metabolism, Lipid, and Sex Hormone Profiles in Females with Metabolic-Related Diseases
por: Li, Xing, et al.
Publicado: (2018)

Adipose endothelial cells mastering adipose tissues metabolic fate
por: Liao, Zhe-Zhen, et al.
Publicado: (2022)

Serum Asprosin Concentrations in Children with Prader–Willi Syndrome: Correlations with Metabolic Parameters
por: Alsaif, Maha, et al.
Publicado: (2022)

Asprosin-neutralizing antibodies as a treatment for metabolic syndrome
por: Mishra, Ila, et al.
Publicado: (2021)

The Effects of Asprosin on Exercise-Intervention in Metabolic Diseases
por: Liu, Lifei, et al.
Publicado: (2022)

The serum level of irisin, but not asprosin, is abnormal in polycystic ovary syndrome patients
por: Chang, Chia Lin, et al.
Publicado: (2019)

Serum Asprosin Correlates with Indirect Insulin Resistance Indices
por: Mirr, Małgorzata, et al.
Publicado: (2023)

Asprosin in pregnancy and childhood
por: Janoschek, Ruth, et al.
Publicado: (2020)

Asprosin in the Paraventricular Nucleus Induces Sympathetic Activation and Pressor Responses via cAMP-Dependent ROS Production
por: Wang, Xiao-Li, et al.
Publicado: (2022)

Serum concentration of asprosin in new-onset type 2 diabetes
por: Naiemian, Shakiba, et al.
Publicado: (2020)

Asprosin is a centrally-acting orexigenic hormone
por: Duerrschmid, Clemens, et al.
Publicado: (2017)

Higher Serum Asprosin Level is Associated with Urinary Albumin Excretion and Renal Function in Type 2 Diabetes
por: Deng, Xia, et al.
Publicado: (2020)

Diet and exercise interventions reduce serum asprosin and the corresponding hypothalamic– pituitary–gonad-axis dysfunction in obese men
por: Yao, Tingting, et al.
Publicado: (2022)

The role of Asprosin in patients with dilated cardiomyopathy
por: Wen, Ming-Shien, et al.
Publicado: (2020)

Serum Levels of Asprosin, a Novel Adipokine, Are Significantly Lowered in Patients with Acromegaly
por: Ke, Xiaoan, et al.
Publicado: (2020)

A state of the art review on the novel mediator asprosin in the metabolic syndrome
por: Luís, Carla, et al.
Publicado: (2020)

Correlation of metabolic characteristics with maternal, fetal and placental asprosin in human pregnancy
por: Hoffmann, Thorben, et al.
Publicado: (2022)

The Asprosin–OLFR734 module regulates appetitive behaviors
por: Liu, Yang, et al.
Publicado: (2020)

Serum Asprosin Level as a New Biomarker in Differentiating Familial Mediterranean Fever Attacks
por: Sipahioglu, Hilal, et al.
Publicado: (2023)

Apelin-13 and Asprosin in Adolescents with Anorexia Nervosa and Their Association with Psychometric and Metabolic Variables
por: Jowik, Katarzyna, et al.
Publicado: (2022)

Apelin-13 and Asprosin in Adolescents with Anorexia Nervosa and Their Association with Psychometric and Metabolic Variables
por: Jowik, K., et al.
Publicado: (2023)

Meal-Related Asprosin Serum Levels Are Affected by Insulin Resistance and Impaired Fasting Glucose in Children With Obesity
por: Corica, Domenico, et al.
Publicado: (2022)

Asprosin in health and disease, a new glucose sensor with central and peripheral metabolic effects
por: Farrag, Mariam, et al.
Publicado: (2023)

Asprosin is positively associated with metabolic syndrome in hemodialysis patients: a cross-sectional study
por: Zhou, Jiandong, et al.
Publicado: (2023)

Plasma Asprosin Concentrations Are Increased in Individuals with Glucose Dysregulation and Correlated with Insulin Resistance and First-Phase Insulin Secretion
por: Wang, Yuren, et al.
Publicado: (2018)

A cross-sectional comparative study on the effects of body mass index and exercise/sedentary on serum asprosin in male college students
por: Huang, Ruiqi, et al.
Publicado: (2022)

Association Between Serum Asprosin and Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus in the Community: A Cross-Sectional Study
por: Xu, Linxin, et al.
Publicado: (2022)

Saliva and Blood Asprosin Hormone Concentration Associated with Obesity
por: Ugur, Kader, et al.
Publicado: (2019)

The Role of Meteorin-Like Peptide and Asprosin in Colon Carcinoma
por: Onat, Elif, et al.
Publicado: (2023)

Increased serum level and impaired response to glucose fluctuation of asprosin is associated with type 2 diabetes mellitus
por: Zhang, Xinyue, et al.
Publicado: (2019)

Serum levels of Asprosin in patients diagnosed with coronary artery disease (CAD): a case-control study
por: Moradi, Nariman, et al.
Publicado: (2021)

Correlation of Serum Asprosin Levels With Normalized Protein Catabolic Rate in Patients Receiving Peritoneal Dialysis Treatment
por: Koyuncu, Sümeyra, et al.
Publicado: (2023)

Asprosin induces vascular endothelial-to-mesenchymal transition in diabetic lower extremity peripheral artery disease
por: You, Mei, et al.
Publicado: (2022)

Aerobic Exercise Training Decreases Hepatic Asprosin in Diabetic Rats
por: Ko, Jeong Rim, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8lept4r9s9vihdnrl1p30o2rt4